Wedbush Upgrades Meridian Biosciences (VIVO) to Neutral Post Q3 Whiff & Selloff
Tweet Send to a Friend
Wedbush upgraded Meridian Biosciences (NASDAQ: VIVO) from Underperform to Neutral with a price target of $17.00.
Analyst, Zarak Khurshid ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Zarak Khurshid ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
